STAT

International trial uses AI to rapidly identify optimal Covid-19 treatments

A major study seeks to turn frenetic attempts to save lives into a running international experiment, with the goal of quickly identifying optimal treatments for #coronavirus patients.
Source: Gene J. Puskar/AP

Treating patients with the never-before-seen Covid-19 is forcing doctors to choose between two equally unpalatable options: try an unproven therapy and hope it works, or treat patients with standard supportive care for severe respiratory disease until a randomized controlled trial establishes the best treatment.

But maybe the choice doesn’t have to be so stark.

A randomized controlled trial ramping up in dozens of hospitals around the world proposes a third way — fusing those two approaches together by using artificial intelligence to home in on the most effective treatments on the fly.

The study seeks to turn frenetic attempts to save is an effective therapy and, if so, for which types of patients. The trial will also allow the researchers to test multiple therapies at once.

Stai leggendo un'anteprima, registrati per continuare a leggere.

Altro da STAT

STAT1 min lettiMedical
STAT+: Pharmalittle: Novavax Faces Raw-materials Shortages For Covid-19 Shot; India Curbs Vaccine Exports
Novavax is delaying signing a contract to supply its Covid-19 vaccine to the European Union because the company is struggling to source raw materials.
STAT1 min lettiMedical
STAT+: Pharmalittle: Feds Sue Walmart Over Opioid Prescriptions; U.S. Buys More Pfizer Vaccine Doses
According to a 160-page civil complaint, Walmart knew its system for detecting suspicious prescriptions was faulty but did little to address the matter as its network of pharmacies filled millions…
STAT1 min lettiMedical
STAT+: Pharmalittle: J&J Seeks Emergency Use For Its Coronavirus Vaccine; Merck Says Parasite Drug Does Not Work On Covid-19
Johnson & Johnson has applied to the FDA for an emergency use authorization for its one-dose Covid-19 vaccine, setting in motion a process all but sure to see a third…